Ultragenyx Pharmaceutical (RARE) Gets a Buy from Piper Sandler
Piper Sandler analyst Allison Bratzel maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price ...
Ultragenyx price target lowered to $115 from $140 at Piper Sandler
Piper Sandler lowered the firm’s price target on Ultragenyx (RARE) to $115 from $140 and keeps an Overweight rating on the shares after analyst ...
Nasdaq26d
Ultragenyx to Participate at Investor Conferences in March
The live and archived webcast of the fireside chat will be accessible from the company’s website at https://ir.ultragenyx.com/events-presentations. Ultragenyx is a ...
Yahoo Finance27d
Ultragenyx Pharmaceutical Inc. (RARE)
NOVATO, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for ...